Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Driehaus Small/Mid Cap Growth Fund 2024 Q3 Investor Letter | Buyside Digest

Back to Fund Profile (Driehaus Small/Mid Cap Growth Fund)

Primary Source Intelligence • Q3 2024 Letter Analysis

Driehaus Small/Mid Cap Growth Fund Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Driehaus Small/Mid Cap Growth Fund. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

QTD+3.12%

Annualized+14.18%

Digest Analysis

Quick Take

"Small/mid cap growth strategy positioned for outperformance as Fed cuts rates and small caps trade at historical valuation discounts. Strong year-to-date performance driven by AI infrastructure, reshoring, and biotech themes."

Executive Summary

Driehaus Small/Mid Cap Growth strategy gained 3.12% in Q3 2024, underperforming the Russell 2500 Growth benchmark by 387 basis points but maintaining strong year-to-date outperformance of 12.8%. The strategy benefits from a favorable environment for small caps including Fed rate cuts, historical valuation discounts, and improving earnings prospects. Key themes driving performance include AI infrastructure spending, reshoring trends, and biotechnology innovation. The portfolio is overweight industrials (26.0% vs 20.1% benchmark) and healthcare (21.8% vs 22.1%), while underweight technology following sector rotation. Technology detracted 202 basis points due to semiconductor weakness, while healthcare and industrials contributed positively. The manager maintains a positive outlook citing sustainable economic growth, strong labor markets, and multiple supportive factors for small cap outperformance. Portfolio positioning emphasizes secular and cyclical growth holdings with strong earnings across diversified themes including infrastructure, commercial aerospace, and data centers.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

68%

CautiousHigh

Moderate (68%)

Strategy demonstrates moderate-high conviction with concentrated sector positioning (26% industrials, 21.8% healthcare) and clear thematic focus on AI, reshoring, and biotech. Manager makes definitive statements about small cap outlook and provides specific positioning rationale. 107 holdings suggests diversified approach but with meaningful sector concentrations.

Growth Outlook

65%

BearishBullish

Bullish (65%)

Manager expresses constructive optimism about markets with positive outlook for U.S. equities, citing favorable trends in economy, inflation, and earnings. Acknowledges risks but believes strengths outweigh bearish concerns. Specific bullish view on small caps supported by multiple catalysts.

Risk Appetite

40%

DefensiveAggressive

Defensive (40%)

Portfolio maintains selective positioning with sector rotations during the quarter. Reduced technology exposure from 22.5% to 16.6% while increasing healthcare and other sectors. Shows measured risk appetite with tactical adjustments rather than aggressive deployment.

Capital Deployment

15%

De-riskingDeploying

De-risking (15%)

Portfolio shows selective rotation activity with technology exposure reduced from 22.5% to 16.6% while healthcare increased from 16.2% to 21.8%. This represents capital rotation rather than net deployment. Cash position at 1.5% suggests limited new capital deployment during the quarter.

Forward Guidance

50%

CautiousExpansionary

Neutral (50%)

Manager indicates continued positive positioning with selective opportunities across sectors. Maintains overweight positions in favored themes while monitoring for better opportunities. Balanced approach to future deployment without aggressive bias.

Language Signal

60%

BearishBullish

Balanced (60%)

Language is predominantly positive with frequent use of terms like 'attractive,' 'supportive,' 'positive outlook,' and 'favorable.' Risk language is present but balanced with opportunity-focused framing. Overall constructive tone throughout the letter.

Perceived Risk

45%

Low RiskElevated

Moderate Risk (45%)

Manager acknowledges several specific risks including economic weakness, earnings trends, political dysfunction, and geopolitical issues. However, risks are mentioned in context of being outweighed by positive factors. Moderate risk awareness without alarm or detailed downside scenarios.

Opportunity Density

65%

ScarceAbundant

Abundant (65%)

Manager sees selective opportunities across multiple sectors and themes, adding new positions in retail, leisure, and homebuilding during the quarter. Positive on small caps broadly with specific opportunities in AI infrastructure, biotech clinical trials, and industrial themes. Constructive view of opportunity set.

Time Horizon

70%

Short-TermLong-Term

Decade+ (70%)

Strategy demonstrates multi-year investment horizon with focus on sustainable themes like AI transformation, reshoring trends, and biotech drug development cycles. Manager discusses historical patterns and long-term structural advantages for small caps. Some near-term catalyst awareness but primarily medium-term thesis orientation.